CRISPR Therapeutics AG CRSP
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 52.44 | 119.05 | -1.35 | -154,764 | -131 | |
| 2025Q3 | 64.81 | 124.79 | -1.14 | -132,059 | -106 | |
| 2025Q2 | 48.64 | 110.65 | -2.40 | -229,324 | -209 | |
| 2025Q1 | 34.03 | 110.04 | -1.58 | -148,424 | -136 | |
| 2024Q4 | 39.36 | 176.42 | -0.42 | -64,588 | -37 | |
| 2024Q3 | 46.98 | 129.46 | -1.00 | -110,130 | -86 | |
| 2024Q2 | 54.01 | 120.89 | -1.49 | -151,261 | -126 | |
| 2024Q1 | 68.16 | 121.33 | -1.43 | -140,587 | -117 | |
| 2023Q4 | 62.60 | 77.68 | 1.13 | 69,583 | 89 | |
| 2023Q3 | 45.39 | 118.50 | -1.41 | -132,411 | -112 | |
| 2023Q2 | 56.14 | 123.96 | -0.99 | -95,223 | -78 | |
| 2023Q1 | 45.23 | 124.62 | -0.67 | -64,487 | -53 | |
| 2022Q4 | 40.65 | 109.57 | -1.40 | -131,541 | -111 | |
| 2022Q3 | 65.35 | 104.15 | -2.24 | -182,388 | -175 | |
| 2022Q2 | 60.77 | 101.97 | 15.11 | -2.40 | -183,260 | -186 |
| 2022Q1 | 62.77 | 100.21 | 12.81 | -2.32 | -175,972 | -179 |
| 2021Q4 | 75.78 | 101.53 | -1.74 | -145,698 | -141 | |
| 2021Q3 | 111.93 | 100.86 | -1.59 | -128,849 | -127 | |
| 2021Q2 | 161.89 | 99.90 | 9.54 | 762,618 | 759 | |
| 2021Q1 | 121.85 | 101.74 | -1.51 | -114,543 | -113 |